Calder Biosciences
Latest round
- Seed
Last raised
- May 2025
Total raised
- Undisclosed
Investors
- 1
About Calder Biosciences
Calder Biosciences Inc. was founded in 2018 and is headquartered in Brooklyn, US. The company specializes in the creation of subunit vaccines. The founder's history and any previous companies are not disclosed.Calder Biosciences specializes in the development of innovative subunit vaccines utilizing its proprietary 3D-Vaxlock™ technology. The core product offerings focus on vaccines designed to provide protection against respiratory syncytial virus (RSV), seasonal and pandemic influenza, and Epstein-Barr virus (EBV). By employing site-specific, covalent crosslinks within proteins, Calder’s vaccines create immunogens that maintain their most effective three-dimensional structure, thereby eliciting stronger immune responses. The company aims to serve a diverse client base that includes healthcare providers, governmental health organizations, and pharmaceutical partners across North America, Europe, and Asia.Calder Biosciences generates revenue through strategic partnerships and collaborations with governmental and private health organizations, focusing on the development and commercialization of its vaccine products. The transactional structure typically involves agreements where partners fund research and development in exchange for access to proprietary technology and future product royalties. Revenue is derived from milestones achieved during the vaccine development process, as well as from the eventual sales of vaccines to healthcare providers and institutions. Key products include the RSV vaccine and universal flu vaccine, which are anticipated to drive significant revenue upon market entry.Calder Biosciences plans to launch new vaccines targeting RSV and a universal flu vaccine in the coming years. The company is actively pursuing expansion into European and Asian markets by 2026.
Who invested in Calder Biosciences
1 investor across 1 round
See all investors in Calder Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
May 20, 2025
Amount
Undisclosed
Investors
Questions about Calder Biosciences
Who invested in Calder Biosciences?
Calder Biosciences has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Calder Biosciences raised?
Calder Biosciences has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Calder Biosciences last raise money?
Calder Biosciences's most recent round on record is a Seed, in May 2025.
What does Calder Biosciences do?
Calder Biosciences is a biotechnology company.
Where is Calder Biosciences headquartered?
Calder Biosciences is headquartered in Brooklyn, US.
Which VCs invest in companies like Calder Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Calder Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Calder Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.